OPEN END TURBO OPTIONSSCHEIN SHORT - RESMED | Market Closed - BOERSE MUENCHEN 02:25:23 2024-05-31 pm EDT | ||
| 3.07 EUR | +8.10% |
|
| 1 month | +20.87% | ||
| 3 months | -50.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 3.07 | +8.10% |
| 24-05-30 | 2.84 | -7.49% |
| 24-05-29 | 3.07 | +4.42% |
| 24-05-28 | 2.94 | +20.99% |
| 24-05-27 | 2.43 | -0.41% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Goldman Sachs |
| WKN | GK9LTQ |
| ISIN | DE000GK9LTQ3 |
| Date issued | 2022-08-25 |
| Strike | 239.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.25 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.03 € |
| Spread % | 0.97% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
206.3
USD
Average target price
216.6
USD
Spread / Average Target
+5.00%
- Stock Market
- Certificates
- Certificat
